Eagle Meds Services
VITRAKVI (LAROTRECTINIB)
Available to sourceHuman Prescription DrugOncology & Specialty

VITRAKVI (LAROTRECTINIB)

20 mg/mL · Solution Concentrate
By Bayer HealthCare Pharmaceuticals Inc.
NDC
50419-392
Route
Oropharyngeal
Therapeutic class
Kinase Inhibitor , Tropomyosin Receptor Kinases Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 100 mL in 1 BOTTLE (50419-392-01)NDC 50419-392-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
VITRAKVI (LAROTRECTINIB)
NDC 50419-392
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source